Skip to main content
SpringerLink
Log in

Weibliche Gonaden

  • Chapter
Klinische Endokrinologie und Stoffwechsel

  • 218 Accesses

Zusammenfassung

Der Hypothalamus spielt als Relaisstation (Umsetzer) eine wichtige Rolle zur Transformation elektrischer Impulse des ZNS in biochemische Signale (sog. Releasing-Hormone: GnRH, CRF, GHRF, TRH und Somatostatin), die durch Neurosekretion über den Hypophysenstiel zur Hypophyse transportiert werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Literatur zu Abschn. 5.7 bis 5.6

  • Adashi E. (1997) Menstrual cyele: Follicular maturation. In: Rabe T., Runnebaum B. (eds) Manual on assisted reproduction. Springer, Berlin Heidelberg Tokyo New York, p 12–21

    Google Scholar 

  • Breckwoldt M., Keck C., (1997) Pubertät und Adoleszenz. In: Keck C., Neulen J., Breckwoldt M. (Hrsg) Endokrinologie, Reproduktionsmedizin, Andrologie. Thieme, Stuttgart

    Google Scholar 

  • Gerhard I., Heinrich U. (1994) Die Pubertät und ihre Störungen. In Runnebaum B., Rabe T. (Hrsg) Gynäkologische Endokrinologie und Fortpflanzungsmedizin. Bd 1, Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Gerhard I., Runnebaum B. (1994) Endokrinologie der Frühschwangerschaft. In: Runnebaum B., Rabe T. (Hrsg) Gynäkologische Endokrinologie und Fortpflanzungsmedizin. Bd 2, Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Gougeon A. (1986) Dynamics of follicular growth in the human: a model from preliminary results. Human Reprod 1:81–87

    CAS  Google Scholar 

  • Grunewald K., Rabe T., Runnebaum B. (1994) Physiologie des menstruellen Zyklus. In: Runnebaum B., Rabe T. (Hrsg) Gynäkologische Endokrinologie und Fortpflanzungsmedizin. Bd 1, Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Grunwald K., Rabe T., Runnebaum B. (1997) Physiology of the menstrual cyele. In: Rabe T., Runnebaum B. (eds) Manual on assisted reproduction. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Kelch R.P., Beitins I.Z. Adolescent sexual development. In: Kappy M.S., Blizzard R.M., Migeon C.J. (eds) Wilkins: The diagnosis and treatment of endocrine disorders in childhood and adolescence. 4th edn, Thomas, Springfield, IL, p 193

    Google Scholar 

  • Schmitt-Mathiesen H., Hepp H. (1998) Gynäkologie und Geburtshilfe. Schattauer, Stuttgart

    Google Scholar 

  • Tanner J.M. (1975) Growth and endocrinology of the adolescent, in: Gardner L.: Endocrine and Genetic Diseases of Childhood. Saunders, Philadelphia London

    Google Scholar 

Literatur zu Absch. 5.7

  • Clayton R.N. (1997) Symptoms, signs and long-term outcomes of adulthood acquired hypopituitarism. In: Lamberts S.W.J. (ed) The diagnosis and Treatment of pituitary deficiency. Bristol, BioScientifica, pp 3–16

    Google Scholar 

  • European and Australian Multicentre Study (1995) Co-treatment with growth hormone and gonadotropin for induction of ovulation in hypogonadotropic patients: a prospective, randomized, placebo-controlled dose respond study. Fertil Steril 64: 917–923

    Google Scholar 

  • Gromoll J., Simoni M., Nordhoff V., Behre H.M., de Geyter C., Nieschlag E. (1996) Functional and clinical consequences of mutations in the FSH receptor. Mol-Cell-Endocrinol 125: 177–182

    PubMed  CAS  Google Scholar 

  • Gromoll J., Simoni M., Nieschlag E. (1996) An activating mutation of the follicle-stimulatung hormone rezeptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab 81: 1367–70

    PubMed  CAS  Google Scholar 

  • Hardelin J.E., Petit C. (1995) A molecular approach to the pathophysiology of the X-Iinked Kallmann’s syndrome. Bailliere’ s Clin Endocrinol Metab 9: 489

    CAS  Google Scholar 

  • Jänicke F., Rjosk H.K., Berg, D., Gioning K. (1983) Pulsatile GnRH-Substitution beim Kallmann-Syndrom der Frau. Geburtshilfe Frauenheilkd 43: 351–354

    PubMed  Google Scholar 

  • Knoll J.H.M., Cheng S.D., LaLande M.(1994) Allele specificity of DNA replication timing in the Angelman/Prader-Willi syndrome imprinte chromosomal region. Nature Genet 6: 41–46

    PubMed  CAS  Google Scholar 

  • Lamberts S.W.J., de Herder W.W., van der Lely A.J. (1998) Pituitary insufficiency. Lancet 352

    Google Scholar 

  • Leyendecker G., Wildt L. (1983) Induction of ovulation with chronic intermittent (pulsatile) administration of GnRH in women with hypothalamic amenorrhoea. J Reprod Fertil 69: 397

    PubMed  CAS  Google Scholar 

  • Paff D.W. et al. (1982) GnRH neurons and other cellular molecular mechanisms for simple mammalian reproductive secretion. Acta abstet gynecol scand 61: 439–443

    Google Scholar 

  • Petit, C. (1993)Molecular basis of the X-chromosome-linked Kallmann’s Syndrome. Trends Endocrinol Metab 4: 8

    PubMed  CAS  Google Scholar 

  • Wood D.F., Franks S. (1998) Hypogonadism in women. In: Grossman A. (ed) Clinical endocrinology. Blackwell Scientific Publications, Oxford, pp 702–717

    Google Scholar 

Literatur zu Abschn. 5.8

  • Bierich J.R., Burgmann G., Kiessling E. (1989) The spontaneous secretion of GH during nocturnal sleep. Monatsschr Kinderhlk 137: 80

    CAS  Google Scholar 

  • Brown D.C., Stirling H.F., Butler G.E., Kelnar C.J., Wu F.C. (1996) Differentiation of normal male prepuberty and hypogonadotrophic hypogonadism using an ultrasensitive luteinizing hormone assay. Horm Res 46: 83–87

    PubMed  CAS  Google Scholar 

  • Crowne E.C., Shalet S.M., Wallace W.H.B., Eminson D.M., Price D.A. (1991) Final height in girls with untreated CDGP. Eur J Pediatr 150: 708–712

    PubMed  CAS  Google Scholar 

  • De la Chapelle A. (1983) Sex chromosome abnormalities. In: Emery A.E.H., Rimoin D.L. (eds) Principles and practice of medical genetics. Vol. I. Churchill Livinstone, Edinburgh, pp 193–215

    Google Scholar 

  • Haavisto A.M., Dunkel L., Petterson K., Huhtaniemi I.(1990) LH measurements by in vitro bioassay and a highly sensitive immunofluorometric assay improve the distinction beetween boys with constitutional delay of puberty and hypogonadotropic hypogonadism. Pediatr Res 27: 211–214

    PubMed  CAS  Google Scholar 

  • Hook E.B., Warburton D. (1983) The distribution of chromosomal genotypes associated with Turner’s syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural x abnormalities of mosaicism. Hum Genet 64: 24–27

    PubMed  CAS  Google Scholar 

  • Nyborg H., Nielson J. (1977) Sex chromosomal abnormalities and cognitive performance: III Field dependence, frame dependence, and failing development of perceptual stability in girls with Turner’s syndrome. J Psychol 96: 205

    PubMed  CAS  Google Scholar 

  • Rosenfeld R.G., Attie K.M., Frane J. et al. (1998) Growth hormone therapy of Turner’s syndrome: beneficial effect on adult height. J Pediatr 132: 319–324

    PubMed  CAS  Google Scholar 

  • Stanhope R., Hindmarsh P., Pringle P.J., Holownia P., Honour J., Brook C.G.D. (1987) Oxondralone in duces a sustained rise in physiological growth hormone secretion in boys with constitutional delay of growth and puberty. Pediatrician 14: 183

    PubMed  CAS  Google Scholar 

  • Waber D.P. (1979) Neuropsychological aspects of Turner’s syndrome. Develop Med Child Neurol 21: 58–70

    PubMed  CAS  Google Scholar 

  • Waldstreicher J., Seminara S.B., Jameson J.L. et al. (1996) The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab 81: 4388–4395

    PubMed  CAS  Google Scholar 

Literatur zu Abschn. 5.9

  • Bettendorf G. (1976) Zum Problem der Gonadotropinbehandlung. Geburtshilfe Frauenheilkd 36: 1017

    Google Scholar 

  • Cates W., Farley T.M.M., Rowe P.J. (1985) Worldwide pattern of infertility: is Africa different? Lancet, p 596–598

    Google Scholar 

  • Collet M., Reniers J., Frost E. et al. (1988) Infertility in Central Africa; infection is the cause. Int J Gynaecol Obstet 26/3: 423–428

    Google Scholar 

  • Daya S. (1989) Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. Br J Obstet gynaecol 96: 275–280

    PubMed  CAS  Google Scholar 

  • Goldstein P., Berrier J., Rosen S., Sacks H.S., Chalmers T.C. (1989) A meta-aanalysis of randomized control trials of progestational agents in pregnancy. Br J Obstet Gynaecol 96: 265–274

    PubMed  CAS  Google Scholar 

  • Graf M.A., Fischer R. (1996) Diagnostik und Therapie beim ovariellen Hyperstimulationssyndrom. Gynäkologe 29: 300

    Google Scholar 

  • Insler V., Melmed H., Lunenfeld B. (1972) The cervical score. Int J Gynecol Obstet 10: 223

    Google Scholar 

  • Kaiser R., Daume E., Lang N. (1968) Ovulationsauslösung mit Clomiphen und Gonadotropin. Med Wochensch 47: 1

    Google Scholar 

  • Lehmann F., Breckwoldt M. (1991) Gonadotropine: drei Jahrzehnte Entwicklung. HMG-Behandlung in der Praxis. Enke, Stuttgart (Bücherei des Frauenarztes Bd 39)

    Google Scholar 

  • Leyendecker G., Wildt L. (1983) Induction of ovulation with chronic intermittent (pulsatile) administration of GnRH in women with hypothalamic amenorrhoea. J Reprod Fertil 69: 397

    PubMed  CAS  Google Scholar 

  • Lunenfeld B., Insler V., Glezerman M. (1992) Diagnosis and treatment of functional infertility, Blackwell, Berlin

    Google Scholar 

  • Rudolf K., Martens E., Hofmann R., Rüting M. (1993) Ergebnisse der Behandlung der funktionellen Sterilität mit Clomiphen. Zentralbl Gynakol 105: 193

    Google Scholar 

  • Schenker J.G., Yarkoni S., Granat M. (1981) Multiple pregnancies following induction of ovulation. Fertil Steril 35: 105

    PubMed  CAS  Google Scholar 

  • Thonneau P., Spira A. (1990) Prevalence of infertility: international data and problems of measurement. Eur J obstet gynecol Reprod Biol 38/1:43–52

    Google Scholar 

Literatur zu Abschn. 5.10

  • Barret-Connor E., Bush T.L. (1991) östrogen and coronary heart disease in women. J Am Med Assoc 265: 1861–1867

    Google Scholar 

  • Christiansen C., Christiansen M.S., Transböl I.(1981) Bone mass in postmenopausal women after withdrawal of oestrogenl ge stagen replacement therapy. Lancet 1: 459–461

    PubMed  CAS  Google Scholar 

  • Collaborative Group on Hormonal Factors in Breast Cancer (1997). Lancet 350: 1047–59

    Google Scholar 

  • Daly E., Vessey M.P., Hawkins M.M., Carson J.L., Gough P., Marsh S. (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348: 977–980

    PubMed  CAS  Google Scholar 

  • Editorial (1995) START beschreibt Aspekte der AlzheimerKrankheit: Ärztliche Hilfe für Demenzkranke. START 3: 6–18

    Google Scholar 

  • Grodstein F., Stampfer M.J., Goldhaber S.Z. et al. (1996) Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 348: 983–987

    PubMed  CAS  Google Scholar 

  • Hemminki E., McPherson K. (1997) Impact ofpostmenopausalhormone therapy on cardiovascularevents and cancer: pooled data from clinical trials. BMJ 315: 149–53

    PubMed  CAS  Google Scholar 

  • Henderson V.W. (1998a) Östrogens and prevention of Alzheimer’s disease. The Management of the Menopause. Annual Review, Parthenon, London, pp 183–192

    Google Scholar 

  • Henderson V.W. (1998b) Sexualsteroide und Alzheimer-Krankheit: Therapeutische Überlegungen. In: ESKA (eds) S. 51–60 (IV. Europäischer Menopausen Kongress, Wien)

    Google Scholar 

  • Hillard T.C., Whitehead M.I. (1991) Hormon Substitutionstherapie-Wege der Verabreichung. In: Medical Communications Services (Hrsg) Kardiovasculäre Wirkungen einer Hormon Substitutionstherapie. Proceedings Internationales Novo Nordisk Symposium Kopenhagen, Dänmark, 1.-2. Februar 1991

    Google Scholar 

  • Hollihn U.K. (1997) The climacteric-a period of transition. Hormone Replacement Therapy and the Menopause, pp 12–107; Schering

    Google Scholar 

  • Hulley S. et al. (1998) Randomized Trial of Ostrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women. JAMA 280: 605–613

    PubMed  CAS  Google Scholar 

  • Jick H., Derby L.E., Myers M.W., Vasilakis C., Newton K.M. (1996) Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal estrogens. Lancet 348: 981–983

    PubMed  CAS  Google Scholar 

  • Kannel W.B., Hjortland M.C., Mcnamara P.M., Gordon T. (1976) Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 85(4)

    Google Scholar 

  • Lilly (1998) Produktinformation EVISTA

    Google Scholar 

  • Potthoff P. et al. (2000) The Menopause Rating Scale (MRS II): methodological standardization in the German population. Zentralbl Gynakol 122(5): 280–6

    PubMed  CAS  Google Scholar 

  • Rabe T., Grunwald K., Vladescu E., Runnebaum B. (1998) Kardiovaskuläres Risiko und Hormonersatztherapie. Der Gynäkologe 10(31):859–869

    Google Scholar 

  • Runnebaum B., Rabe T., Holst T. von, Wüster C. (1994) Klimakterium der Frau. In: Runnebaum B., Rabe T. (eds) Gynäkologische Endokrinologie und Reproduktionsmedizin, Bd 1, Springer, Berlin Heidelberg New York Tokyo, S 513–588

    Google Scholar 

  • Sarrel P. (1989) Effects of ovarian steroids on the cardiovascular system. In: Ginsburg J. (ed) The circulation of the female. Parthenon, Carnforth, New Jersey, pp 117–140

    Google Scholar 

  • Schiff I., Komarov Sela H., Cramer D., Tulchinsky D., Ryan K.J. (1982) Endometrial hyperplasia in women on cyclic or continuous es trogen regimens. Fertil Steril 37: 79–82

    PubMed  CAS  Google Scholar 

  • Smith-Bindmann R. et al. (1998) JAMA 280: 1510–1517

    Google Scholar 

  • Swales J.D. (1996) Cardiovascular complications and the menopause. In: Messerli F.H. (ed) (1996) Hypertension in postmenopausal women, Dekker, pp 139–148

    Google Scholar 

  • Holst T. von(1982) Hormonelle Diagnostik im Klimakterium der Frau. Habilitationsschrift, Ruprecht-Karls-Universitä ts-Heidelberg

    Google Scholar 

  • Whitehead M.I. (1986) Prevention of endometrial abnormalities. Acta Obstet Gynecol Scand Suppl 134: 81–91

    CAS  Google Scholar 

Literatur zu Abschn. 5.77

  • Anasti J.N., Flack M.R., Froehlich J., Nelson L.M., Nisula B.C. (1995) A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 80: 276–279

    PubMed  CAS  Google Scholar 

  • Balducci R., Boscherini B., Mangianlini A., Morellini M., Toscano V. (1994) Isolated precocious pubarche: an approach. J Clin Endocrinol Metab 79: 582

    PubMed  CAS  Google Scholar 

  • Blanco-Garcia M., Evain-Brian D., Roger M., Job J.C. (1985) Isolated menses in prepubertal girls. Pediatrics 76: 43

    PubMed  CAS  Google Scholar 

  • Crowley W.F., Comite F., Vale W., Rivier J., Loriaux D.L., Cutler G.B. (1981) Therapeutic use for pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrin Metab 52: 370

    Google Scholar 

  • Feuillan P.P., Forster C.M., Pescowitz O.H. (1986) Treatment of precocious puberty in the McCune Albright syndrome with the aromatase inhibitor testolactone. New Engl J Med 315: 1115

    PubMed  CAS  Google Scholar 

  • Freni-Titulaer L.W., Cordero J.F., Haddock L., Lebron G., Martinez R., Mills J.L. (1986) Premature thelarche in Puberto Rico. Am J Dis Child 140: 1263

    PubMed  CAS  Google Scholar 

  • Garibaldi L.R., Picco P., Magier S., Chevli R., Aceto T. (1991) Serum luteinizing hormone concentrations, as measured by a sensitive immunoradiometric assay in children with normal precocious and delayed pubertal development.J Clin Endocrinol Metab 72: 888

    PubMed  CAS  Google Scholar 

  • Ibanez L., Potau N., Virdis R. et al. (1993) Postpubertal outcome in girls diagnosed of premature pub arche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76: 1599

    PubMed  CAS  Google Scholar 

  • Ilicki A., Lewin R.P., Kauli R., Kaufman H., Schachter A., Laron Z. (1984) Premature thelarche-maternal history and sex hormone secretion in 68 girls. Acta Paediatr Scand 73: 756

    PubMed  CAS  Google Scholar 

  • Kauli R., Galatzer A., Kornreich L., Lazar L., Pertzelan A., Laron Z. (1997) Final height of girls with central precocious pub erty untreated vs. treated with cyproterone acetate or GnRH analogue. A comperative study with reevaluation of predictions by the Bayley-Pinneau method. Horm Res 47(2):54–61

    PubMed  CAS  Google Scholar 

  • Korth-Schütz S., Levine L.S., New M.I. (1976) Dehydroepiandrosterone sulfate (DS) levels, a rapid test for abnormal adrenal androgen secretion. J Clin Endocrinol Metab 42: 1005

    PubMed  Google Scholar 

  • Lee P.A., Dop C. van, Migeon C. (1986) McCune Albright Syndrome: longterm follow up. JAMA 256: 1980

    Google Scholar 

  • Lee P.A. (1994) Laboratory monitoring of children with precocious puberty. Arch Pediatr Adolesc Med 148: 369

    PubMed  CAS  Google Scholar 

  • Manasco P.K., Pescowitz O.H., Hill S.C., Jones J.M., Barnes K.M., Hench K.D., Loriaux D.L., Cutler G.B. (1989) Six year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty. J Pediatr 115: 105

    PubMed  CAS  Google Scholar 

  • Marshall W.A., Tanner J.M. (1969) Variations in the pattern of pubertal changes in girls. Arch Dis Child 44: 291–296

    PubMed  CAS  Google Scholar 

  • Nelson K.G. (1983) Premature thelarche in children born prematurely. J Pediatr 103: 756

    PubMed  CAS  Google Scholar 

  • Oostdijk W., Rikken B., Schreuder S. et al. (1996) Final height in central precocious puberty after long term treatment with slow release GnRH agonist. Arch Dis Child 75: 292–297

    PubMed  CAS  Google Scholar 

  • Rosenfield R.L. (1994) Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs. J Pediatr 124: 989–991

    PubMed  CAS  Google Scholar 

  • Saggese G., Bertelloni S., Baroncelli G.I., Battini R., Franchi G. (1993) Reduction of bone density: an effect of gonadotropin releasing hormone agonist treatment in central precocious puberty. Eur J Pediatr 152: 7 A

    Google Scholar 

  • Sippell W.G., Partsch C.J., Hümmelink R., Lorenzen F. (1992) Langzeittherapie mit dem Retard-LHRH-Agonisten Decapeptyl-Depot bei Mädchen mit Pubertas praecox vera. Ergebnisse einer internationalen Multizenterstudie. Gynäkologe 24: 108

    Google Scholar 

  • Temeck J.W., Pang S., Nelson C., New M.I. (1987) Genetic defects of steroidogenesis in premature pub arche. J Clin Endocrinol Metab 64: 609

    PubMed  CAS  Google Scholar 

  • Weinstein L.S., Shenker A., Gejman P.V., Merino M.J., Friedman E., Spiegel A.M. (1991) Activating mutations ofthe stimulating G-protein in the McCune Albright Syndrome. New Engl J Med 325: 1688

    PubMed  CAS  Google Scholar 

Literatur zu Abschn. 5.72

  • Baron J. (1974) Diagnostik und Therapie des Hirsutismus. Zentralb Gynakol 5: 129–142

    Google Scholar 

  • Bruchowsky N. (1979) Molekulare Wirkung von Androgenen und Antiandrogenen, 7-21. In: Hammerstein J., LachnitFixon U., Neumann F., Plewig G. (Hrsg) Androgenisierungserscheinungen bei der Frau. 1. Aufl, Excerpta Medica, Amsterdam, S 7–21

    Google Scholar 

  • Ferriman D., Gallwey J.D. (1961) Clinical assessement of body ha ir growth in women. J Clin Endocr 21: 1440–1447

    PubMed  CAS  Google Scholar 

  • Grunwald (1998) Persönliche Mitteilungen

    Google Scholar 

  • Leidenberger F. (1997) Klinische Endokrinologie für Frauenärzte. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Rosenfield R.L. (1971) Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute females. J Clin Endocrinol 32: 717–728

    CAS  Google Scholar 

  • Rabe T., Runnebaum B. (1994) Funktionsteste und Untersuchungsmethoden in der gynäkologischen Endokrinologie und Fortpflanzungsmedizin. In: Runnebaum B., Rabe T. (Hrsg) Gynäkologische Endokrinologie und Fortpflanzungsmedizin, Springer, Berlin Heidelberg new York Tokyo, S 29–98

    Google Scholar 

  • Rabe T., Grunwald K., Runnebaum, B. (1994) Androgenisierungserscheinungen bei der Frau. In: Runnebaum B., Rabe T. (Hrsg.) Gynäkologische Endokrinologie, Springer, Berlin Heidelberg New York Tokyo, S 589–665

    Google Scholar 

Literatur zu Abschn. 5.73

  • Blanche H., Vexiau P., Clauin S. et al. (1997) Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Hum Genet 101: 56–60

    PubMed  CAS  Google Scholar 

  • Dörr H.G., Schulze E. (1998) Das adrenogenitale Syndrom. Gynäkologe 31: 539–548

    Google Scholar 

  • Dörr H.G., Sippell W.G., Willig R.P. (1992) Pränatale Therapie und Diagnostik des adrenogenitalen Syndroms mit 21-Hyxdroxylasedefekt. Mschr Kinderheilkd 140: 661–663

    Google Scholar 

  • Geley S., Kapelari K. et al. (1996) CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 ß-hydroxylase deficiency. J Clin Endocr Metab 81: 2896–2901

    PubMed  CAS  Google Scholar 

  • Hughes I.A., Dyas J., Robinson J., Walker R.F., Fahmy D.R. (1985) Monitoring treatment in congenital adrenal hyperplasia. Use of serial measurements of 17-OH-progesterone in plasma, capillary blood, and saliva. Ann NY Acad Sci 458: 193–202

    PubMed  CAS  Google Scholar 

  • Jaresch S., Komely E., Kley H.K., Schlaghecke R. (1992) Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocr Metab 74: 685–689

    PubMed  CAS  Google Scholar 

  • Laue L., Merke D.P., Jones J.V., Bames K.M., Hili S., Cutler G.B. Jr. (1996) A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia. J Clin Endocr Metab 81: 3535–3539

    PubMed  CAS  Google Scholar 

  • Lifton R.P., Dluhy R.G. et al. (1992) A chimaeric 11ß-hydroxylase/aldosterone synthase gene causes Glucocorticoid-remidiable aldosteronism and human hypertension. Nature 355: 262–265

    PubMed  CAS  Google Scholar 

  • Lin D., Sugawara T. et al. (1995) Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267: 1828–1831

    PubMed  CAS  Google Scholar 

  • Mauthe I., Laspe H., Knorr D. (1977) Zur Häufigkeit des kongenitalen adrenogenitalen Syndroms (AGS) München 1963-1972. Klin Padiatr 189: 172–176

    PubMed  CAS  Google Scholar 

  • Miller W.L. (1988) Molecular biology of steroid hormone synthesis. Endocr Rev 9: 295–318

    PubMed  CAS  Google Scholar 

  • Miller W.L. (1994) Genetics, diagnosis and management of 21-hydroxylase deficiency. J Clin Endocriniol Metab 78: 241–246

    CAS  Google Scholar 

  • Miller W.L., Auchus R.J., Geiler D.H. (1997) The regulation of 17,20 lyase activity. Steroids 62: 133–142

    PubMed  CAS  Google Scholar 

  • Morel Y., Miller W.L. (1991) Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 20: 1–68

    PubMed  CAS  Google Scholar 

  • New M.I. (1992) Genetic dis orders of adrenal hormone synthesis. Horm Res 37 (Suppl 3):22–33

    PubMed  CAS  Google Scholar 

  • New M.I. (1994) 21-Hydroxylase deficiency congenital adrenal hyperplasia. J Steroid Biochem Molec Biol 48: 15–22

    PubMed  CAS  Google Scholar 

  • Pang S. (1997) Congenital adrenal hyperplasia. Bailliere’s Clin Obstet Gynacol 11: 281–306

    CAS  Google Scholar 

  • Pang S. (1997) Congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 26: 853–891

    PubMed  CAS  Google Scholar 

  • Pang S., Shook M.K. (1997) Current status of neonatal sereening for congenital adrenal hyperplasia. Curr Opin Pediatr 9: 419–423

    PubMed  CAS  Google Scholar 

  • Prader A. (1958) Vollkommen männliche äußere Genitalentwicklung und Salzverlustsyndrom bei Mädchen mit kongenitalem adrenogenitalem Syndrom. Helv Pediatr Acta 1: 5–15

    Google Scholar 

  • Sakkal A.H., Zhang L. (1996) Studies of 3ß-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated delta 5-steroid levels. J Clin Endocr Metab 81: 3961–3965

    Google Scholar 

  • Schmidt-Matthiesen H., Hepp H. (1998) Gynäkologie und Geburtshilfe. Schattauer, Stuttgart

    Google Scholar 

  • Silbernagl A., Despopoulus (1983) Taschenatlas der Physiologie. 2. Aufl. Thieme, Stuttgarl New York

    Google Scholar 

  • Simard J., Rheaume E. et al. (1993) Molecular basis of congenital adrenal hyperplasia due to 3ß-hydroxysteroid dehydrogenase deficiency. Mol Endocr 7: 716–728

    CAS  Google Scholar 

  • Speiser P.W., Dupont J. et al. (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Inverst 90: 584–595

    CAS  Google Scholar 

  • Speiser P.W., New M.I. (1994) Prenatal diagnosis and treatment of cungenital badrenal hyperplasia. J Pediatr Endocrinol 7: 183–191

    PubMed  CAS  Google Scholar 

  • Stocco D.M., Clark B.J. (1997) The role of steroidogenic acute regulatory pro tein in adrenal and gonadal steroidogenesis. Steroids 62: 29–36

    PubMed  CAS  Google Scholar 

  • White P.C., Cumow K.M., Pascoe L. (1994) Disorders of steroid 11ß-hydroxylase isozymes. Endocr Rev 15: 421–438

    PubMed  CAS  Google Scholar 

  • Wilson R.C., Mercado A.B., Cheng K.C., New M.I. (1995) Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80: 2322–2329

    PubMed  CAS  Google Scholar 

  • Yanase T., Simpson E.R., Waterinan M.R. (1991) 17a-hydroxylase/ 17,20-lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12: 91–108

    PubMed  CAS  Google Scholar 

  • Zachmann M., Tassinari D., Prader A. (1983) Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 ß-hydroxylase deficiency. J Clin Endocr Metab 56: 222–229

    PubMed  CAS  Google Scholar 

Literatur zu Abschn. 5.74

  • Bergfeld W.F. (1979) Diffuser Haarausfall bei Frauen. In: Orfanos C.E. (Hrsg) Haar und Haarkrankheiten. Fischer, Stuttgart, S 493–503

    Google Scholar 

  • Bergfeld W.F. (1995) Androgenetic alopecia: an autosomal dominant disorder. Am J Med 98: 95S–98S

    PubMed  CAS  Google Scholar 

  • Ebling F.J.G. (1986) Hair follicles and associated glands as androgen targets. Clin Endocrinol Metab 15: 319–339

    PubMed  CAS  Google Scholar 

  • Freinkel R., Freinkel N. (1972) Hair growth in hypothyreoidism. Arch Dermatol 106: 349–352

    PubMed  CAS  Google Scholar 

  • Gerhard I. (1992) Erst ausschwemmen, dann Dauer-Prophylaxe. In: Medical Tribune 22: 37

    Google Scholar 

  • Headington J. (1984) Transverse microscopic anatomy of the human scalp. Arch Dermatol 120: 449–456

    PubMed  CAS  Google Scholar 

  • Klobusch J., Rabe T., Gerhard I., Runnebaum B. (1992) Alopezie und Umweltbelastungen. Klin Lab 38: 469–476

    CAS  Google Scholar 

  • Laue L., Merke D.P., Jones J.V., Bames K.M., Hili S., Cutler G.B. Jr. (1996) A preliminary study of flutamide, testolactone and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab 81(10):3535–3539

    PubMed  CAS  Google Scholar 

  • Ludwig E. (1977a) Androgenetische Alopezie. Arch Dermatol 113: 109

    PubMed  CAS  Google Scholar 

  • Ludwig E. (1977b) Classification of types of androgenetic alopecia (common baldness) occuring in the female sex. Br J Dermatol 97: 247–254

    PubMed  CAS  Google Scholar 

  • Maguire H.C., Kligman A.M. (1964) Hair plucking as a diagnostic test. J Invest Dermatol 43: 77–80

    Google Scholar 

  • Orfanos C.E. (1990) Androgenetic alopecia: Clinical aspects and treatment. In: Orfanos C.E., Happle R. (Hrsg) Hair and Hair Diseases. Springer, Berlin Heidelberg New York Tokyo, pp 485–521

    Google Scholar 

  • Salomon T. (1968) Genetic factors on male alopecia. In: Baccaredda-Boy A., Morretti G., Frey J.R. (Hrsg) Biopathology of pattern alopecia. Karger, Basel, S 39–49

    Google Scholar 

  • Sawaya M.E., Price V.H. (1997) Different levels of 5 a-reductase type 1 and 11, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 109: 296–300

    PubMed  CAS  Google Scholar 

  • Schurz B., Schmidt J.B., Merka M., Huber J.C. (1986) Zur klinischen Bedeutung des TRH-Tests bei der Sterilitätsabklärung und beim androgenetischen Effluvium. Gynakol Rundsch 26 (Suppl 2):195–198

    Google Scholar 

  • Tronnier H., Essig F. (1976) Zur internen Therapie des Haarausfalles. Acta Dermatol 2: 147–154

    Google Scholar 

  • Venning V.A., Dawber R.P.R. (1988) Patterned androgenic alopecia in women. J Am Acad Dermatul 18: 1073–1077

    CAS  Google Scholar 

  • Verbow J.L. (1978) Common baldness occuring in females only in one generation. Brit J Clin Pract 32: 261–262

    Google Scholar 

  • Zaun H., Perret C. (1990) Intemal diseases affecting hair growth. In: Orfanos C.E., Happle R. (ed) Hair and Hair Diseases. Springer, Berlin Heidelberg New York Tokyo, pp 587–600

    Google Scholar 

Literatur zu Abschn. 5.75

  • Axelrod L.R., Goldzieher J.W. (1962) The polycystic ovary. III. Steroid biosynthesis in normal and polycystic ovarian tissue. J Clin Endocrinol Metab 22: 359–368

    Google Scholar 

  • Burghen G.A., Givens J.R., Kitabchi A.E. (1980) Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease. J Clin Endocrinoi Metab 50: 113

    CAS  Google Scholar 

  • Chang R.J., Geffner M.E. (1985) Associated nonovarian problems of polycystic ovarian disease: insulin resistance. Clin Obstet Gynecol 12: 675–685

    CAS  Google Scholar 

  • Chang R.J., Nakamura R.M., Judd H.L., Kaplan S.A. (1983) Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57: 356–359

    PubMed  CAS  Google Scholar 

  • Erickson G.F., Case E. (1983) Epidermal growth faetor antagonizes ovarian theea-interstitial eytodifferentiation. Mol Cell Endocrinol 31: 71–76

    PubMed  CAS  Google Scholar 

  • Goldzieher J.W., Green J.A. (1962) The polyzystie ovary. I. Clinical and histologie features. J Clin Endocrinol Metabol 22: 325–335

    CAS  Google Scholar 

  • Kahn C.R., Flier J.S., Bar R.S., Areher J.A., Gorden P., Marhn M.M., Roth J. (1976) The syndromes of insulin resistanee and aeanthosis nigricans. N Engl J Med 294: 739–747

    PubMed  CAS  Google Scholar 

  • Laatikainen T.J., Apter D.L., Paavonen J.A., Wahlstrom T.R. (1980) Steroids in ovarian and peripheral venous blood in polyeystie ovarian disease. Clin Endocrinol 13: 125–134

    CAS  Google Scholar 

  • Pasquali R., Casimirri F., Venturoli S. et al. (1983) Insulin resistanee in patients with polyeystie ovaries: its relationship to bodyweight and androgen levels. Aeta Endocrinol (Copenh) 104: 110–116

    CAS  Google Scholar 

  • Pasquali R., Fabbri R., Venturoli S., Paradisi R., Antenucci D., Melchionda N. (1986) Effeet of weight loss and antiandrogenie therapy on sex hormone blood levels and insulin resistanee in obese patients with polyeystic ovaries. Am J Obstet Gynecol 154: 139–144

    PubMed  CAS  Google Scholar 

  • Short R.V. (1962) Further observations on the defective synthesis of ovarian steroids in the Stein-Leventhal syndrome. J Endocrinol 24: 359–368

    PubMed  CAS  Google Scholar 

  • Short R.V., London D.R. (1961) Defective synthesis of ovarian steroids in the Stein-Leventhal syndrome. BMJ 1: 1724–1731

    PubMed  CAS  Google Scholar 

  • Shoupe D., Lobo R.A. (1984) The intluence of androgens on insulin resistance. Fertil Steril 41: 385–388

    PubMed  CAS  Google Scholar 

  • Smith S., Ravniear V.A., Barbieri R.L. (1987) Androgen and insulin response to an oral glucose challenge in hyperandrogenie women. Fertil Steril 48: 72–77

    PubMed  CAS  Google Scholar 

  • Smith K.D., Steinberger E., Perioff W.H. (1965) Polycystic ovarian disease. Areport of 301 patients. Am J Obstet Gynecol 93: 994–1004

    PubMed  CAS  Google Scholar 

  • Stuart C.A., Peters E.J., Prince M.J., Richards G., Cavallo A., Meyer W.J. (1986) Insulin resistance with acanthosis nigricans: the roles of obesity and androgen exeess. Metabolism 13: 197–204

    Google Scholar 

Literatur zu Abschn. 5.76

  • Abs R., Parizel P.M., Beckers A. (1991) Acute effects of Parlodel LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma. J Endocrinol Invest 14: 135–138

    PubMed  CAS  Google Scholar 

  • Katznelson I., Alexander J.M., Bikkal H.A., Jameson J.L., Klibanski A. (1992) Imbalanced follicie-stimulating hormone betasubunit hormone biosynthesis in human pituitary adenomas. J Clin Endocrinol Metab 74: 1343–1351

    PubMed  CAS  Google Scholar 

  • Kontogeorgos G., Kovacs K., Horvath E., Scheithauer B.W. (1993) Null cell adenomas, oncocytomas, and gonadotroph adenomas of the human pituitary: an immunocytochemical and ultrastructural analysis of 300 cases. Endocr Pathol 4: 20–27

    Google Scholar 

  • Kovacs K., Horvath E., Rewcastle N.B., Ezrin C. (1980) Gonadotroph cell adenoma of the pituitary in a woman with longstanding hypogonadism. Arch Gynecol 229: 57–65

    PubMed  CAS  Google Scholar 

  • Kovacs K., Horvath E., Ryan N., Ezrin C. (1980) Null cell adenomas of the human pituitary. Virchows Arch (A) 387: 165–174

    CAS  Google Scholar 

  • Kovacs K., Asa S.L., Horvath E. (1991) Cytogenesis of non-functioning pituitary adenoma (abstract). Endocr Pathol 2: 177–179

    Google Scholar 

  • Lamberts S.W., Verleun T., Oosterom R., Hotland L., van Ginkel L.A., Loeber J.G., van Vroonhoven C.C., Stefanko S.Z., de Jong F.H. (1987) The effects of bromocriptine, Thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro. J Clin Endocrinol Metab 64: 524–30

    PubMed  CAS  Google Scholar 

  • Mermillion J.A., Gatchair-Rose A., Svec F. (1995) Pituitary Tumor and low gonadotropins in a patient with Turner’s Syndrome. J State Med Soc 147: 540–543

    Google Scholar 

  • Nicolis G., Shimshi M., Allen C., Halmi N.S., Kourides I.A. (1988) Gonadotropin-producing pituitary adenoma in a man with long-standing primary hypogonadismn. J Clin Endocrinol Metab 66: 237–241

    PubMed  CAS  Google Scholar 

  • Polkowska J., Berault A., Hurbain-Kosmath I., Jolly G., Jutisz M. (1991) Bihormonal celle producing gonadotropins and prolactin in a rat pituitary tumor cell line (RC-4B/C). Neuroendocrinology 54: 267–273

    PubMed  CAS  Google Scholar 

  • Samaan N.A.; Stepanas A.V., Danziger J., Trujillo J. (1979) Reactive pituitary abnormalities in patients with Klinefelter’s and Turner’s Syndromes. Arch Intern Med 139: 198–201

    PubMed  CAS  Google Scholar 

  • Sano T., Yamada S. (1994) Histologie and immunohistochemical study of clinically nonfunctioning pituitary adenomas: special reference to gonadotropin-positive adenomas. Pathol Int 44: 697–703

    PubMed  CAS  Google Scholar 

  • Sassolas G., Lejeune H., Trouillas J., Forest M.G., Claustrat B., Lahlou N., Loras B. (1988) Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 67: 180–185

    PubMed  CAS  Google Scholar 

  • Spertini F., Deruaz J.P., Perentes E., Pelet B., Gomez F. (1986) Luteinizing hormone (LH) and prolactin-releasing pituitary tumor: possible malignant transformation of the LH cell line. J Clin Endocrinol Metab 62: 849–854

    PubMed  CAS  Google Scholar 

  • Vance M.L., Ridgway E.C., Thorner M.O. (1985) Follicle-stimulating hormone—and alphasubunit-secreting pituitary tumor treated with bromocriptine. J Clin Endocrinol Metab 61: 580–584

    PubMed  CAS  Google Scholar 

  • Young W.F. Jr., Scheithauer B.W., Kovaes K.T., Horvath E., Davis D.H., Randall R.V. (1996) Gonadotroph adenoma of the pituitary gland: a clinicopathologic analysis of 100 eases. Mayo Clin Proc 71: 649–656

    PubMed  Google Scholar 

Download references

Authors
  1. C. v. Hagens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Heinrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Kiesewetter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Rabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Runnebaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Schulze
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Vladescu
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik IV, Universitätsklinikum Tübingen, Otfried-Müller-Straße 10, 72076, Tübingen, Deutschland

    Peter P. Nawroth

  2. Abteilung Innere Medizin I, Medizinische Universitätsklinik und Poliklinik Heidelberg, Bergheimer Straße 58, 69115, Heidelberg, Deutschland

    Reinhard Ziegler

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

v. Hagens, C. et al. (2001). Weibliche Gonaden. In: Nawroth, P.P., Ziegler, R. (eds) Klinische Endokrinologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56784-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56784-1_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62970-9

  • Online ISBN: 978-3-642-56784-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation